➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Dow
Express Scripts
Mallinckrodt
McKinsey

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

MPI INDIUM DTPA IN 111 Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Mpi Indium Dtpa In 111 patents expire, and what generic alternatives are available?

Mpi Indium Dtpa In 111 is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in MPI INDIUM DTPA IN 111 is indium in-111 pentetate disodium. There are twenty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the indium in-111 pentetate disodium profile page.

Summary for MPI INDIUM DTPA IN 111
US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Clinical Trials: 60
DailyMed Link:MPI INDIUM DTPA IN 111 at DailyMed
Drug patent expirations by year for MPI INDIUM DTPA IN 111
Recent Clinical Trials for MPI INDIUM DTPA IN 111

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tomopath Inc.Early Phase 1
InvicroEarly Phase 1
Janssen Research & Development, LLCEarly Phase 1

See all MPI INDIUM DTPA IN 111 clinical trials

US Patents and Regulatory Information for MPI INDIUM DTPA IN 111

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare MPI INDIUM DTPA IN 111 indium in-111 pentetate disodium INJECTABLE;INTRATHECAL 017707-001 Feb 18, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Colorcon
Johnson and Johnson
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.